Manager, Regulatory Affairs (Cmc)

Corbus Pharmaceuticals Holdings, Inc. Norwood , MA 02062

Posted 4 days ago

The Manager, Regulatory Affairs (CMC) will lead in the planning, preparation and review of investigational new drugs applications (INDs), Clinical Trial Applications, new drug applications (NDAs), market authorization application (MAA) and all related annual reports, DMFs, amendments, supplements as well as their ongoing maintenance. The Manager will also lead the preparation and review of regulatory submissions (CMC sections) as well as CMC related responses and inquiries from regulatory agencies. We are seeking a talented Manager to help develop (CMC) regulatory strategies and provide (CMC) regulatory guidance to cross-functional teams and key stakeholders while acting as the primary regulatory (CMC) contact for ongoing projects and responsibilities.

This is a newly created position based on growth

PRIMARY RESPONSIBILITIES:

  • Lead the preparation and review (of CMC sections) of relevant regulatory submissions, as well as the interactions and responses with regulatory agencies

  • Develop global CMC regulatory strategies for one or more investigational and marketed products

  • Collaborate with US & International regulatory colleagues in development of global CMC regulatory strategies and submissions

  • Manage regulatory assessment and guidance on product compliance topics including change controls, deviations, and GMP investigations

  • Work effectively on cross-functional teams and be the primary regulatory CMC contact for assigned products and projects

  • Become a key resource for relevant personnel to provide regulatory advice to help guide CMC development activities

Skills/Requirements

SKILLS & REQUIREMENTS:

  • Bachelor's Degree required, Advanced Degree preferred in appropriate field with 5+ years Regulatory experience in biotech or pharmaceutical industry

  • Regulatory affairs (CMC) experience (or relevant experience), preferably in Phase 3 studies

  • Solid understanding of full drug development process

  • Thorough understanding of U.S. and Euro regulatory requirements and the operating characteristics or regulatory agencies

  • Experience in developing or assisting the regulatory strategy of all stages of drug development from IND to market approval

  • Familiarity with accelerated regulatory pathways a plus

  • RAPS certification a plus

  • Ability to identify and remedy key regulatory issues and to anticipate potential regulatory hurdles

  • Energetic, positive team player

Corbus Culture:

Corbus is a close-knit team of almost 100 employees who are high-achievers,innovative, creative and, above all else, passionate about what we do. We hirefor personality as well as for skill.

You must thrive in an entrepreneurial and autonomous environment where youwill succeed based on your contribution and work ethic, not on your title orrank. At Corbus we take pride in our "family" atmosphere where each person'scontribution is vital to our success. As a Corbus employee, you are empoweredto think creatively and be proactive in your approach. There is no place forpolitics or red tape here. Positive, team-oriented people work at Corbus andare rewarded with fun perks like weekly food deliveries to our kitchen, amonthly in-house massage therapist, company-paid classes with Title Boxing, andorganized company activities and outings. Additionally, Corbus offers anattractive, comprehensive benefits package.

About Corbus:

Corbus Pharmaceuticals Holdings, Inc. (NASDQ: CRBP) is a Phase 3clinical-stage pharmaceutical company focused on the development andcommercialization of novel therapeutics to treat inflammatory and fibroticdiseases by leveraging its industry leading pipeline of endocannabinoidsystem-targeting drug candidates. The Company's lead product candidate,Lenabasum, is a novel, synthetic, oral, selective cannabinoid receptor type 2(CB2) agonist designed to resolve chronic inflammation and fibrotic processes.Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis,dermatomyositis, and systemic lupus erythematosus.

Corbus licensed the exclusive worldwide rights to develop, manufacture andmarket drug candidates from more than 600 novel compounds targeting the endocannabinoidsystem from Jenrin Discovery LLC. The pipeline includes CRB-4001, a 2ndgeneration, peripherally-restricted, selective cannabinoid receptor type 1(CB1) inverse agonist specifically designed to eliminate blood-brain barrierpenetration and brain CB1 receptor occupancy that mediate the neuropsychiatricissues associated with first-generation CB1 inverse agonists. Potentialindications for CRB-4001 include NASH, primary biliary cholangitis, idiopathicpulmonary fibrosis, radiation-induced pulmonary fibrosis, myocardial fibrosisafter myocardial infarction and acute interstitial nephritis, among others.CRB-4001 is scheduled to enter a Phase 1 study in 2019 followed a NationalInstitutes of Health (NIH)-funded first-in-patient Phase 2 study.

www.corbuspharma.com

Corbus Pharmaceuticals Holdings, Inc. is an equal opportunity employer


upload resume icon
See if you are a match!

See how well your resume matches up to this job - upload your resume now.

Find your dream job anywhere
with the LiveCareer app.
Mobile App Icon
Download the
LiveCareer app and find
your dream job anywhere
App Store Icon Google Play Icon
lc_ad

Boost your job search productivity with our
free Chrome Extension!

lc_apply_tool GET EXTENSION

Similar Jobs

Want to see jobs matched to your resume? Upload One Now! Remove
Temporary Manager Regulatory Affairs

Corbus Pharmaceuticals Holdings, Inc.

Posted 2 months ago

VIEW JOBS 12/8/2018 12:00:00 AM 2019-03-08T00:00 JobDescription: The Manager of Regulatory Affairsrole will work to develop and implement regulatory strategy on assignedprograms. This person will work closely with cross-functional teams and subjectmatter experts to support development and finalization of study-related regulatorydocuments, manage various routine regulatory submissions, assist in preparationand related submissions for meetings with various Health Authorities. Ensure compliance with safety and periodicreporting requirements for investigational drugs. Responsibilities: * Collaboratewith regulatory and cross-functional colleagues on clinical document reviews * Preparationand submission of regulatory filings in collaboration with RegulatoryOperations * Expeditedsafety reporting, as needed * Prepareand review sections of regulatory submissions for IND/CTA original submissionsand amendments, orphan designations, and pediatric investigation plans * Participatein negotiations with regulatory agencies to resolve issues and coordinate preparationand submission of responses to various Health Agency's questions * Actas primary regulatory liaison with medical writers, clinical, statistics, toxicologyand DMPK teams as well as external CROs to provide regulatory support for trialinitiation and ongoing maintenance needs * Reviewtechnical documentation and regulatory documents to ensure conformance withapplicable regulatory guidelines, and requirements including SOPs * Participatein regulatory intelligence activities, monitor advisory committees, regulatoryguidelines and trends. Skills/Requirements Knowledge and Skills: * BS/BAin biochemistry, chemistry, biology or related life/health sciences. Advanceddegree (MD, PhD, PharmD, MS) a plus. * Minimum3-5 years of regulatory experience in a biotech/pharma company. * Experiencewith the regulatory needs of clinical/preclinical development of biopharmaceuticalsis required. * Excellentproject management skills, as well as a good understanding of the underlyingscience. * Experiencewith preparation of initial INDs, CTAs, DSURs and meeting briefing documents.Experience with NDA, or MAA or accelerated development programs is a plus. * Mustbe knowledgeable in ICH, FDA and EMA guidelines. * Knowledgeof Good Clinical Practice (GCP). * Strong attention to detail,excellent written and verbal communication skills, comfort in a teamenvironment, able to work independently with minimal supervision. * Abilityto influence across multiple functions and embrace diversity of approaches inproblem solving. Corbus Culture: Corbus is a close-knit team of almost 100 employees who are high-achievers,innovative, creative and, above all else, passionate about what we do. We hirefor personality as well as for skill. You must thrive in an entrepreneurial and autonomous environment where youwill succeed based on your contribution and work ethic, not on your title orrank. At Corbus we take pride in our "family" atmosphere where each person'scontribution is vital to our success. As a Corbus employee, you are empoweredto think creatively and be proactive in your approach. There is no place forpolitics or red tape here. Positive, team-oriented people work at Corbus andare rewarded with fun perks like weekly food deliveries to our kitchen, amonthly in-house massage therapist, company-paid classes with Title Boxing, andorganized company activities and outings. Additionally, Corbus offers anattractive, comprehensive benefits package. About Corbus: Corbus Pharmaceuticals Holdings, Inc. (NASDQ: CRBP) is a Phase 3clinical-stage pharmaceutical company focused on the development andcommercialization of novel therapeutics to treat inflammatory and fibroticdiseases by leveraging its industry leading pipeline of endocannabinoidsystem-targeting drug candidates. The Company's lead product candidate,Lenabasum, is a novel, synthetic, oral, selective cannabinoid receptor type 2(CB2) agonist designed to resolve chronic inflammation and fibrotic processes.Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis,dermatomyositis, and systemic lupus erythematosus. Corbus licensed the exclusive worldwide rights to develop, manufacture andmarket drug candidates from more than 600 novel compounds targeting the endocannabinoidsystem from Jenrin Discovery LLC. The pipeline includes CRB-4001, a 2ndgeneration, peripherally-restricted, selective cannabinoid receptor type 1(CB1) inverse agonist specifically designed to eliminate blood-brain barrierpenetration and brain CB1 receptor occupancy that mediate the neuropsychiatricissues associated with first-generation CB1 inverse agonists. Potentialindications for CRB-4001 include NASH, primary biliary cholangitis, idiopathicpulmonary fibrosis, radiation-induced pulmonary fibrosis, myocardial fibrosisafter myocardial infarction and acute interstitial nephritis, among others.CRB-4001 is scheduled to enter a Phase 1 study in 2019 followed a NationalInstitutes of Health (NIH)-funded first-in-patient Phase 2 study. www.corbuspharma.com Corbus Pharmaceuticals Holdings, Inc. is an equal opportunity employer Corbus Pharmaceuticals Holdings, Inc. Norwood MA

Manager, Regulatory Affairs (Cmc)

Corbus Pharmaceuticals Holdings, Inc.